Cardiology Fellow @MGHHeartHealth | Former Internal Medicine Resident @MGHMedicine | Alum: @UCC | Irish ☘️ | Sports fanatic
Feb 28 • 14 tweets • 5 min read
The eagerly awaited 2025 ACC/AHA ACS guidelines were released yesterday! Congrats to @SVRaoMD @DrM_ODonoghue and all the co-authors
1/ Here are some of my takeways 2/ The guideline states it applies to individuals with Type 1 MI rather than those with SCAD, type 2 MI, and MINOCA. This is important as prior ACC/AHA NSTEMI guidelines did not explicitly state this.
Dec 9, 2021 • 6 tweets • 7 min read
Session IV of #BacktoHeart21 covering all things cardiometabolic disease occuring now!
First up, @JJheart_doc discusses SGLTI2 for T2DM and ASCVD!
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization now published!
Here are my top takeaways!
Thread/
Link: jacc.org/doi/10.1016/j.…2/ For stable CAD and left main stenosis, CABG is recommended (Class 1). PCI is a reasonable option if low-medium anatomic complexity and if equally suitable to PCI compared to CABG (Class IIa)
My 15 highlights 💡from the 2020 ESC NSTE-ACS guideline:
1. Hs troponins recommeded over conventional assays 🧪 2. ESC 0'1 and 0'2 algorithms preferred over 0'3 3. TTE recommended for all patients. 4. If rule-out using ED algorithm but still have concern for ACS, a non-invasive modality is preferred to invasive coronary angio 5. Pre-treatment with P2Y12 not recommended prior to invasive coronary angiogram